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Dendritic leukocytes (DL)' from lymphoid tissues are specialized antigen-present-
ing cells that initiate immune responses (1) . There is evidence that related cells in
transplanted tissues (passenger leukocytes) are the principal stimulators of rejection
but it is not knownwhere they initially activate host T cells (2) . The prevailing view
is that for fully vascularized organ allografts sensitization occurs within the graft
itself (i.e., peripherally) (3-5), while for skin grafts it occurs in the draining lymph
nodes (i.e ., centrally) (6-8) . In this report we show that donor-derived MHC class
II-positive (Ia+) DL migrate rapidly out of mouse cardiac allografts into the
recipients' spleens where they home to the peripheral white pulp and associate pre-
dominantly with CD4 + T lymphocytes . This provides a novel route for central sen-
sitization against fully vascularized allografts, and most likely represents a pathway
by which immune responses are generated against antigens on blood-borne DL
emigrating from peripheral tissues .
While dendritic cells (DC) isolated from lymphoid tissues, lymph, and blood can
initiate immune responses, their precursors in skin, Langerhans cells (LC), lack this
ability. LC, however, can mature into potent stimulatory cells (9) and migrate as
veiled cells via the lymph into lymph nodes (10, 11) ; by a second route purified lym-
phoid DC that are administered intravenously can migrate from blood into spleen
and home to T areas (12, 13) . Bone marrow-derived Ia+ cells with dendritic mor-
phology have been identified in a wide variety ofnonlymphoid organs and are pre-
sumed to be DL (14) . Recent work suggests these cells in kidney, heart, and perhaps
other nonlymphoid organs are immature precursors more closely resembling LC
than lymphoid DC (Austyn, J., and C. Larsen, unpublished data) .
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Mice
Male C57BL/10 (H-26), BALB/c (H-2d), CBA/Ca (H-2k), and C3H/He (H-2'), mice were
obtained from Olac Ltd. (Bicester, Oxon., UK) or from theBiomedical Services Unit,John
Radcliffe Hospital, University of Oxford.
Cardiac Transplantation
BALB/c hearts were transplanted as fully vascularized, heterotopic grafts into C3H/He
recipients essentially as described (15). Technical success was >95% and the total ischemic
time was generally 20-25 min. The amount of donor blood transferred to recipients in the
grafts was minimized by removing -0.7 ml blood from the vena cava, injecting 1 ml
heparinized saline (300 U/ml) at 4°C, and allowing this to circulate before severing the ab-
dominal aorta and vena cava. Donor hearts were then dissected out and gently massaged
between cotton buds in saline at 4°C.
Measurement of the Volume of Blood Contained in a Transplanted Heart
The average volume of blood contained within a graft was determined using "Cr-labeled
mouseerythrocytes essentially as described (16):cellscontaining 150,000 cpm in 0.25 ml PBS
were injected intravenously into three mice and after20-30mina sample ofperipheral blood




The following mAbs were used as tissue culture supernatants for
first stage antibodies: TIB122 anti-leukocyte common antigen, 2AG2 anti-Fc receptor type
II, M1/70(TIB 128) anti-C3bireceptor, GK1.5 anti-CD4, TIB 105 anti-CD8, TIB 104anti-
CD5, TIB 145 anti-B220, TIB 146 anti-B p50, 2D2C anti-Pgp-1.1 (Ly24), B21-2 (TIB 229)
anti-lab,°, all of which are rat monoclonals, and MKD6 anti-lad which is a mouse mAb (an-
tibodies in reference 17). For two-color staining biotinylated YTS 191, rat IgG2b anti-CD4




Multiple cryosections (7 14m) of heart and spleen from transplanted
and normal mice embedded in OCTcompound (Miles Scientific) were prepared and stored
at -30°C until use. For staining, the sections were fixed in acetone for 10 min, air dried
and rehydrated in PBS with 1% fetal calf serum.
Two-Color Immunofuorescent Staining
Materials and Methods
Resident cardiac leukocytes (see text) were examined by two-color immunofluorescence
using MKD6 mouse anti-Iad and TRITC-conjugated goat anti-mouse Ig (Sigma Chem-
ical Co., St. Louis, MO) as a first step. The sections were then blocked with normal mouse
serum before staining with various rat anti-mouse mAbs followed by FITC-mouse anti-rat
Ig (Boehringer-Mannheim Biochemicals, Indianapolis, IN).
Localization ofMigratory DL within Spleen.
￿
Sections of recipient spleens 2-3 d after trans-
TABLE I

















1 101 223 0.1086 2.2 2.0
2 134 184 0.0874 1.4 1.6
3 100 191 0.0995 1.9 1.9
Mean 0.0985 1.8 1.8LARSEN ET AL.
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plantation were first stained with TRITC-conjugated goat anti-mouse Ig and blocked with
normal mouse serum before staining donor DL with B21-2 and FITC mouse anti-rat Ig.
Immunoperozidase Staining . Frozen sections were stained using B21-2 anti-lab,d or 2D2C
anti-Pgp-1.1 (not shown) followed by peroxidase-conjugated goat anti-rat Ig (Sigma Chem-
ical Co.) adsorbed with normal mouse serum, after first eliminating endogenous peroxidase
by incubating the sections in 10 U/ml glucose oxidase type VS (SigmaChemical Co.) in 10 mM
glucose for 30 min at 37°C. Peroxidase activity was detected using H202-DAB (3,3' diamino-
benzidine tetrahydrochloride; Polysciences Inc., Warrington, PA) as a chromogen. After coun-
terstaining with Harris' hematoxylin (BDH, Ltd. Poole, UK) the slides were dehydratedand
mounted in DPX (BDH, Ltd.).
Two-color Immunogold-Peroxidase Staining.
￿
Sections were prepared as for one-color peroxi-
dase staining and Iad-positive cells were stained with B21-2 and gold-conjugated goat anti-rat
Ig (Janssen Life Sciences Products, Olen, Belgium) adsorbed with normal mouse serum.
After blocking with 5% normal rat serum, sections were incubated with biotinylated YTS
191 (anti-CD4) or YTS 169 (anti-CD8) followed by peroxidase-conjugated goat anti-biotin
(Sigma Chemical Co.). Silver enhancement (IntenSE-M; Janssen Life Sciences Products) was
performed before development with DAB.
An ocular grid was used to enumerate discrete lad-positive cells in tissue sections ofheart
grafts (2 hearts/time point, 10 fields/sample). From day 3 onwards lad was induced on other
graft elements, as notedby others (19), so DL could only be quantified in areas lacking gener-
alized la expression; a similar approach has been used elsewhere (20).
Iad-positive cells in recipient spleens were counted similarly (6-12 sections/sample) and
cross-sectional areas were measured using an Optimax V image analyzer in order to stan-
dardize the number of cells per unit area. Statistical analysis was carried out usingStudent's
t-test or X2 with Yates correction.
Results and Discussion
Using two-color immunofluorescent staining we identified two resident leukocyte
common antigen-positive populations in mouse hearts: a strongly Ia', Fc receptor
type II' (FcRII+ ), phagocyte glycoprotein-1' (Pgp-1 +), and complement receptor
type III (CR3)-weak population of similar phenotype to LC, comprising the presump-
tive DL; and a smaller group which is Ia- FcRII+ , Pgp-1 }, and CR3-strong, per-
haps comprising tissue macrophages or precursors of the la' population. Normal
hearts contained no cells that stained for B cell markers (anti-Ig, B220, and TIB146)
or T cell markers (CD4, CD5, CD8).
We wished to determine whether donor DL could migrate via the blood from vas-
cularized organ allografts into recipients' spleens after transplantation (an efflux of
these cellsin the draining lymphhaving been reported previously [5]). BALB/c hearts
(H-2d, Pgp-1.1) were transplanted into C3H/He recipients (H-2k, Pgp-1 .2) and we
examined the grafts for changes in density of resident DL, as well as the recipient
spleens for entry of cells bearing donor alloantigens between 1-6 d later (rejection
normally occurs at 8-12 d).
Over the first 4 d after transplantation there was a marked reduction in the number
of la' DL in the graft, from a mean of 95.7 mm-2 (at day 0) to 9.2 mm-2 (Table
II). At the same time that donor DL were leaving the grafts, strongly lad-positive
cells with dendritic morphology entered the recipients' spleens (Fig. 1 a and b, and
Table II). These cells also labeled for the donor-strain Pgp-1 allele that is expressed
by DL, further suggesting the cells were of donor origin, although we can not ex-
clude the less likely possibility they were host-derived cells that had acquired donor
alloantigens in a form recognizable by the antibodies. Donor cells were readily ap-
parent by day 1, and maximum numbers were present between days 2 and 4 after
transplantation, representing a total of _104 cells per spleen at any given time (Table310
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FIGURE 1 .
￿
Donor dendritic leukocytes enter recipient spleens after transplantation. Sections
of C3H/He spleens from recipients of BALB/c hearts 2 d after transplantation stained to show
the presence of lad-positive cells, note the central arteriole (a, x250), and their dendritic mor-




Frequencies of Donor la+ DL in Cardiac Allografts and Recipient Spleens
Discrete lad positive cells in tissue sections of heart grafts (2 hearts/time point,
10 fields/sample) were enumerated using an ocular grid. lad-positive cells in
recipient spleens were counted similarly (6-12 sections/sample) and cross-sec-
tional areas were measured. By multiplying the mean number ofstained cells
per 10-mm2 section (7 gm thick) by the approximate number of sections in
a spleen 1 .5 cm in length (2,000), it is possible to estimate X104 cells/spleen
are present at any time on days 2-4.
A significant difference compared with normal nontransplanted BALB/c hearts
(day 0) (p < 0.001).
At day 6 generalized la induction precluded assessment ofthe density of DL.
II, legend), but they were not detectable at day 6. Similar findings were made in
otherstrain combinations (BALB/c -"CBA/Ca, C57BL/10-CBA/Caand BALB/c
-~ C57BL/10; data not shown).
The donor cells in the spleen were not cells such as B cells or monocytes derived
from thevery smallamountofblood remaining in the heart graft. First, precautions
were taken to avoid significant transfer ofbloodinthe donorheart (see above). Second,
experiments revealed the volume ofblood transferred in a graft to be 1.8 t 0.2 ..1.
(Table I). When 2.5 ul of BALB/c blood (diluted to 0.25 ml) was administered to
each of three C3H/He mice, the frequency of lad-positive cells in spleen 2 d later
was 0.2 t 0.1/10 mm2, indicatingthe donor cells in spleens oftransplant recipients
were not derived from blood. Hence, the donor lad positive cells found in the re-
cipient spleen must have come from the resident Ia+ leukocytes of grafted heart
which we would term dendriticleukocytes, there beingno resident B cells in normal
cardiac tissues.
To determine where donor la' cells were localized within the spleen, double-
labeling techniques were used (Fig. 1). Donor cells were found exclusively within
the peripheral white pulp that contains primarily B cells and some T cells, or at
theborder ofthiswith central white pulp (dense T areas) (Fig. 1 c). On close inspec-
tion, donor cells did not appear to express surface or cytoplasmic Ig, providingfur-
Donor dendritic leukocytes localize in splenic peripheral white pulp and associate with
CD4' T cells. Immunofluorescence to show donor lad-positive cells (green) within the B cell
rich areas (red) and at the border of B cell and T cell areas (c, x 250). Immunogold-peroxidase
staining to show donor DL (black) in association with CD4' T cells (brown) (d, x 250) and an
lad
_Positive
DL in a cluster of CD4' T cells (e, x400), and in contrast, donor DL not in contact




Mean DL t SE
in cardiac allografts
per mm2 section
Mean donor DL t SE
in recipient spleens
per 10 mm2 cross-section
0 95.7 t 8.2 0
1 47.5 t 7.3' 5.0 t 0 .8
2 17.0 t 3.0` 11 .8 t 1 .3
3 9.2 t 2.0" 10.4 t 0.8
4 20.5 t 5.1' 9.6 t 1 .7
6 t 0312
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ther evidence against their beingB cells. Double staining with Ia and CD4 orCD8
mAbs revealed that 78% ofdonor cells were associated with CD4' T cells (Fig. 1,
dand e), either singly or in a cluster, but only 14% appeared to be in contact with
CD8' T cells (Fig. 1 f), a highly significant difference (X2 = 39, p = 0.0001).
Thesefindings demonstrate a novel migratoryroute forDL that expresshigh levels
ofalloantigens and/or foreign peptide/MHC complexes from a vascularized organ
allograft into the spleen (via blood, since thespleen lacks alymphatic supply), con-
comitant with theirdisappearance from the graft. Previous investigators have noted
such a reduction in both allografts and isografts, but failed to detect migration into
lymphoid tissues, perhapsbecause endogenous peroxidase activity was not sufficiently
blocked to allow detection of the relatively small numbers of cells (20). While the
number of DL in the spleen at any time point is only -10¢ there may be a con-
tinuous flux into and out of this tissue, and a single injection of even this number
of donor-strain lymphoid DC alone can precipitate allograft rejection (16, 21).
Studies have shown that depletion ofDL from transplanted tissues not only has
a profound influence on cellular rejection (22, 23), but also prevents the develop-
ment ofgraft-specific antibodies (24). This is particularly interesting in light ofthe
juxtaposition of donor DL with both T and B cells, consistent with the idea that
DC play a role in the initiation of cell-mediated and T cell-dependent antibody
responses in vivo, as has been shown in vitro (25). This distribution is somewhat
different from that seen after intravenous administration of syngeneic splenic DC,
which appear to home to the central white pulp (12). Possibly after transplantation
the allogeneic DL encounter alloreactive Tcells in the peripheral white pulp, soon
aftertheir migration out ofthemarginal zone, and theirsubsequent movement into
the central white pulp is inhibited. Alternatively, the migratory properties of DL
from nonlymphoid tissues may be distinct from those oflymphoid DC. Additional
studies will be required to distinguish between these possibilities.
DL maymigrate into blood in response to cytokines that are released during the
inflammatory reaction that occurs after transplantation. Results of older studies
favoring peripheral sensitization against fully vascularizedorgan allografts can now
be reinterpreted as central sensitization due to migration of blood-borne DL into
the spleen, and in physiological situations this most likely provides a pathway for
inducing responses against antigens (e.g., viruses) derived from peripheral tissues.
It isquite conceivablethat DL reside innonlymphoid organs as precursors and pro-
cess antigens fromthe environment, before they develop into mature DC and subse-
quentlymigrateintolymphoid tissueswith theabilityto presentthesepeptide/MHC
complexes and activate resting T cells (9, 26). Studies to define the signals (e.g.,
cytokines) that regulate maturation and migration of DL from peripheral tissues
may providenew strategies to overcome allograft rejection and manipulate antigen-
dependent immune responses, e.g., vaccination.
Summary
It hasbeen along-standingdogmathathost sensitization against fully-vascularized
organ allografts occurs peripherally within the graft itself. In this report we show
that donor-derived MHC class II-positive (Ia') DL migrate rapidly out ofmouse
cardiac allografts intothe recipients' spleenswheretheyhome tothe peripheral whitepulp and associate predominantly with CD4+ T lymphocytes. This provides a novel
route for central sensitization against fully vascularized allografts, and most likely
represents a pathway by which immune responses are generated against antigens
on blood-borne DL emigrating from peripheral tissues.
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